Category: Category 4

Cell and gene therapies represent a revolutionary leap in medicine, offering the potential to treat previously untreatable diseases and transform patient outcomes. However, their complex nature presents significant challenges across the entire biotech industry. As these therapies transition from the research phase to commercial scale, the associated supply chain and manufacturing hurdles have become critical…